Halozyme Therapeutics
HALO
#2408
Rank
C$8.59 B
Marketcap
$67.57
Share price
-3.62%
Change (1 day)
29.99%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of September 2024 : C$2.16 Billion

According to Halozyme Therapeutics's latest financial reports the company's total debt is C$2.16 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)

2013201620192022$0.5B$1B$1.5B$2B$2.5B0companiesmarketcap.com

Total debt by year

Year Total debt Change
2023-12-31C$1.98 B-2.7%
2022-12-31C$2.04 B82.92%
2021-12-31C$1.11 B120.59%
2020-12-31C$0.50 B-3.67%
2019-12-31C$0.52 B205.42%
2018-12-31C$0.17 B-32.33%
2017-12-31C$0.25 B-12.61%
2016-12-31C$0.29 B321.11%
2015-12-31C$69.12 M19.47%
2014-12-31C$57.86 M9.21%
2013-12-31C$52.98 M71.26%
2012-12-31C$30.93 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$0.34 B-84.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$44.89 B 1,968.92%๐Ÿ‡บ๐Ÿ‡ธ USA
C$19.03 B 777.17%๐Ÿ‡บ๐Ÿ‡ธ USA
C$96.10 B 4,328.88%๐Ÿ‡บ๐Ÿ‡ธ USA
C$36.72 B 1,592.70%๐Ÿ‡ซ๐Ÿ‡ท France
C$51.57 B 2,276.82%๐Ÿ‡บ๐Ÿ‡ธ USA